SYNAPSE Research Management Partners S.L   Report issue

For profit Phase 2
Founded: Madrid Spain (2009)

Organization Overview

First Clinical Trial
2017
NCT02790996
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

vancomycin (Vancocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neonatal Sepsis (Phase 2)

Sepsis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1